title: Hormonal counterregulation failure in rats is related to previous hyperglycaemia-hyperinsulinaemia.
abstract: Hyperglycaemia and hyperinsulinaemia were induced in rats by a continuous 48-h infusion with glucose. Discontinuation of glucose infusion resulted in marked, persistent hypoglycaemia. To further delineate the mechanism underlying this condition, we measured counterregulatory hormone levels, in vivo glucose kinetics (glucose production = rate of appearance = Ra; glucose utilization = rate of disappearance = Rd), and in vitro gluconeogenesis during the 48-h postinfusion period. Prior to cessation of glucose infusion, Rd was increased 6-fold when compared to control rats, whereas Ra was totally abolished. During the first hour after the end of glucose infusion, Ra increased and Rd decreased (but was still higher than Ra), inducing hypoglycaemia which stabilized after 1 h at ¿¿126¿¿3.5 mmol/l when both Ra and Rd became equal. Despite hypoglycaemia, plasma glucagon and catecholamine levels did not increase during the 3-to 36-h time interval. The increase in Ra during the first hour post-infusion was not related to changes in counterregulatory hormone response. The increase in glucose production was accounted for by glycogenolysis, as shown by total depletion in liver glycogen within 6 h and thereafter by gluconeogenesis. In vitro experiments using isolated hepatocytes suggested that gluconeogenesis was supported during the first 24 h by substrates entering the pathway beyond the step catalysed by the PEPCK enzyme. Thereafter, lactate became the major substrate, and this condition was associated with a progressive rise in glucagon concentration. It is concluded that 48 h of hyperglycaemia/hyperinsulinaemia resulted in a failure of counterregulatory hormonal response to hypoglycaemia. Yet, despite this lack of counterregulatory response, hepatic gluconeogenesis was stimulated in response to hypoglycaemia.
authors.affiliation: Laboratoire de Physiopathologie de la Nutrition, Université Paris 7-Denis Diderot, France. magnan@paris7.jussieu.fr
authors.forename: C
authors.initials: C
authors.lastname: Magnan
authors.forename: M C
authors.initials: MC
authors.lastname: Laury
authors.forename: P
authors.initials: P
authors.lastname: Adnot
authors.forename: L
authors.initials: L
authors.lastname: Doaré
authors.forename: L
authors.initials: L
authors.lastname: Boucontet
authors.forename: M
authors.initials: M
authors.lastname: Kergoat
authors.forename: L
authors.initials: L
authors.lastname: Pénicaud
authors.forename: A
authors.initials: A
authors.lastname: Ktorza
authors.forename: M
authors.initials: M
authors.lastname: Gilbert
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000502:physiology; D002395:Catecholamines / Q000378:metabolism*; D004435:Eating / Q000502:physiology; D005260:Female; D005934:Glucagon / Q000378:metabolism*; D005990:Glycerol / Q000097:blood; D006943:Hyperglycemia / Q000503:physiopathology*; D006946:Hyperinsulinism / Q000503:physiopathology*; D007003:Hypoglycemia / Q000378:metabolism; D007700:Kinetics; D019344:Lactic Acid / Q000097:blood; D008099:Liver / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012636:Secretory Rate
chemical_list: D001786:Blood Glucose; D002395:Catecholamines; D019344:Lactic Acid; D005934:Glucagon; D005990:Glycerol